Short version of the International Myalgic Encephalomyelitis Consensus Criteria for GP's and consultants

Myalgic Encephalomyelitis: International Consensus Criteria
J Intern Med. 2011. doi: 10.1111/j.1365-2796.2011.02428.x

Carruthers BM, van de Sande MI, de Meirleir KL, Klimas NG, Broderick G, Mit-chell T, Staines D, Powles ACP, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa J, Murovska M, Pall ML, Stevens S.

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2796.2011.02428.x/abstract

MYALGIC ENCEPHALOMYELITIS:
INTERNATIONAL CONSENSUS CRITERIA

Adult and Pediatric
Clinical and Research

Myalgic encephalomyelitis is an acquired neurological disease with complex global dysfunctions.
Pathological dysregulation of the nervous, immune and endocrine systems, with impaired cellular energy metabolism and ion transport are prominent features.
Although signs and symptoms are dynamically interactive and causally connected, the criteria are grouped by regions of pathophysiology to provide general focus.

A patient:
 will meet the criteria for post-exertional neuroimmune exhaustion (A),
 at least one symptom from three neurological impairment categories (B),
 at least one symptom from three immune/gastro-intestinal/genitourinary impairment categories (C), and
 at least one symptom from energy metabolism/transport impairments (D).

Short version of the International Myalgic Encephalomyelitis Consensus Criteria for GP's and consultants.pdf

FULL version of the International Myalgic Encephalomyelitis Consensus Criteria.pdf